Vaccine with virus-like nanoparticles effective treatment for RSV, study finds
A vaccine containing virus-like nanoparticles, or microscopic, genetically engineered particles, is an effective treatment for respiratory syncytial virus (RSV), according to researchers at Georgia State University.
Aug 3, 2015
0
12